Author:
Ramos Linares Sara,Breña Atienza Joaquín,Cháfer Rudilla Matilde,Ríos Rull Pablo,Cabello Rodríguez Ana,Merino Alonso Javier
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy,General Medicine,Pharmacology (medical),Pharmacology
Reference10 articles.
1. Klatersky J. Side effects of ifosfamide. Oncology. 2003;65(suppl 2):7–10.
2. Rieger C, Fiegl M, Tischer J, Ostermann H, Schiel X. Incidence and severity of ifosfamide-induced encephalopathy. Anti-Cancer Drugs. 2004;15:347–50.
3. Ajithkumar T, Parkinson C, Shamshad F, Murray P. Ifosfamide encephalopathy. Clin Oncol. 2007;19(2):108–14.
4. Santoro A, Magagnoli M, Spina M, Pinotti G, Siracusano L, Michieli M, et al. Ifosfamide, gemcitabine, vinorelbine: a new induction regimen for refractory, relapsed Hodgkin’s lymphoma. Haematologica. 2007;92(1):35–41.
5. Common Terminology Criteria for Adverse Events v3.0 (CTCAE). National Cancer Institute. Available: http://www.ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcaev3.pdf . (Visit on April 2009).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献